PDB Short entry for 1YC3 HEADER CELL CYCLE 21-DEC-04 1YC3 TITLE CRYSTAL STRUCTURE OF HUMAN HSP90ALPHA COMPLEXED WITH TITLE 2 DIHYDROXYPHENYLPYRAZOLES COMPND MOL_ID: 1; COMPND 2 MOLECULE: HEAT SHOCK PROTEIN HSP 90-ALPHA; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: SEQUENCE DATABASE RESIDUES 8-222; COMPND 5 SYNONYM: HSP 86, ATP BINDING DOMAIN OF HSP90 ALPHA; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: HSPCA, HSP90A, HSPC1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 511693; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PRSET KEYWDS CELL-CYCLE, CANCER, DRUG DESIGN, CELL CYCLE EXPDTA X-RAY DIFFRACTION AUTHOR A.KREUSCH,S.HAN,A.BRINKER,V.ZHOU,H.CHOI,Y.HE,S.A.LESLEY,J.CALDWELL, AUTHOR 2 X.GU REVDAT 4 14-FEB-24 1YC3 1 REMARK SEQADV REVDAT 3 24-FEB-09 1YC3 1 VERSN REVDAT 2 01-MAR-05 1YC3 1 DBREF REVDAT 1 22-FEB-05 1YC3 0 JRNL AUTH A.KREUSCH,S.HAN,A.BRINKER,V.ZHOU,H.S.CHOI,Y.HE,S.A.LESLEY, JRNL AUTH 2 J.CALDWELL,X.J.GU JRNL TITL CRYSTAL STRUCTURES OF HUMAN HSP90ALPHA-COMPLEXED WITH JRNL TITL 2 DIHYDROXYPHENYLPYRAZOLES. JRNL REF BIOORG.MED.CHEM.LETT. V. 15 1475 2005 JRNL REFN ISSN 0960-894X JRNL PMID 15713410 JRNL DOI 10.1016/J.BMCL.2004.12.087 REMARK 2 REMARK 2 RESOLUTION. 2.12 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.0 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.12 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 48.33 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 99.2 REMARK 3 NUMBER OF REFLECTIONS : 12896 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.184 REMARK 3 FREE R VALUE : 0.259 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 640 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.12 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.25 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.00 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.2200 REMARK 3 BIN FREE R VALUE : 0.2800 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : 102 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.028 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1687 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 27 REMARK 3 SOLVENT ATOMS : 167 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 17.90 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 31.80 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 6.75000 REMARK 3 B22 (A**2) : 0.78000 REMARK 3 B33 (A**2) : -7.53000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 1.65000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.22 REMARK 3 ESD FROM SIGMAA (A) : 0.18 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.32 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.22 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.018 REMARK 3 BOND ANGLES (DEGREES) : 2.000 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 24.00 REMARK 3 IMPROPER ANGLES (DEGREES) : 1.120 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1YC3 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 17-JAN-05. REMARK 100 THE DEPOSITION ID IS D_1000031364. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 19-NOV-03 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 9.00 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.54 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : OSMIC MIRROR REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 12896 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.100 REMARK 200 RESOLUTION RANGE LOW (A) : 48.330 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.2 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : 0.11400 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 10.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.12 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.25 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.0 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.32000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.50 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 6000, LICL, PH 9.0, VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 277K, PH 9.00 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 22.41450 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A -27 REMARK 465 ARG A -26 REMARK 465 GLY A -25 REMARK 465 SER A -24 REMARK 465 HIS A -23 REMARK 465 HIS A -22 REMARK 465 HIS A -21 REMARK 465 HIS A -20 REMARK 465 HIS A -19 REMARK 465 HIS A -18 REMARK 465 GLY A -17 REMARK 465 MET A -16 REMARK 465 ALA A -15 REMARK 465 SER A -14 REMARK 465 MET A -13 REMARK 465 THR A -12 REMARK 465 GLY A -11 REMARK 465 GLY A -10 REMARK 465 GLN A -9 REMARK 465 GLN A -8 REMARK 465 MET A -7 REMARK 465 GLY A -6 REMARK 465 ARG A -5 REMARK 465 ASP A -4 REMARK 465 LEU A -3 REMARK 465 TYR A -2 REMARK 465 ASP A -1 REMARK 465 ASP A 0 REMARK 465 ASP A 1 REMARK 465 ASP A 2 REMARK 465 LYS A 3 REMARK 465 ASP A 4 REMARK 465 ARG A 5 REMARK 465 TRP A 6 REMARK 465 GLY A 7 REMARK 465 SER A 8 REMARK 465 ASP A 9 REMARK 465 LYS A 224 REMARK 465 GLU A 225 REMARK 465 ARG A 226 REMARK 465 ASP A 227 REMARK 465 LYS A 228 REMARK 465 GLU A 229 REMARK 465 VAL A 230 REMARK 465 SER A 231 REMARK 465 ASP A 232 REMARK 465 ASP A 233 REMARK 465 GLU A 234 REMARK 465 ALA A 235 REMARK 465 GLU A 236 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 40 50.48 -105.90 REMARK 500 ASP A 66 74.26 -166.28 REMARK 500 LEU A 107 47.22 -109.58 REMARK 500 ALA A 166 -144.87 78.35 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 4BC A 237 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1YC1 RELATED DB: PDB REMARK 900 RELATED ID: 1YC4 RELATED DB: PDB DBREF 1YC3 A 9 236 UNP P07900 HS90A_HUMAN 8 235 SEQADV 1YC3 MET A -27 UNP P07900 CLONING ARTIFACT SEQADV 1YC3 ARG A -26 UNP P07900 CLONING ARTIFACT SEQADV 1YC3 GLY A -25 UNP P07900 CLONING ARTIFACT SEQADV 1YC3 SER A -24 UNP P07900 CLONING ARTIFACT SEQADV 1YC3 HIS A -23 UNP P07900 CLONING ARTIFACT SEQADV 1YC3 HIS A -22 UNP P07900 CLONING ARTIFACT SEQADV 1YC3 HIS A -21 UNP P07900 CLONING ARTIFACT SEQADV 1YC3 HIS A -20 UNP P07900 CLONING ARTIFACT SEQADV 1YC3 HIS A -19 UNP P07900 CLONING ARTIFACT SEQADV 1YC3 HIS A -18 UNP P07900 CLONING ARTIFACT SEQADV 1YC3 GLY A -17 UNP P07900 CLONING ARTIFACT SEQADV 1YC3 MET A -16 UNP P07900 CLONING ARTIFACT SEQADV 1YC3 ALA A -15 UNP P07900 CLONING ARTIFACT SEQADV 1YC3 SER A -14 UNP P07900 CLONING ARTIFACT SEQADV 1YC3 MET A -13 UNP P07900 CLONING ARTIFACT SEQADV 1YC3 THR A -12 UNP P07900 CLONING ARTIFACT SEQADV 1YC3 GLY A -11 UNP P07900 CLONING ARTIFACT SEQADV 1YC3 GLY A -10 UNP P07900 CLONING ARTIFACT SEQADV 1YC3 GLN A -9 UNP P07900 CLONING ARTIFACT SEQADV 1YC3 GLN A -8 UNP P07900 CLONING ARTIFACT SEQADV 1YC3 MET A -7 UNP P07900 CLONING ARTIFACT SEQADV 1YC3 GLY A -6 UNP P07900 CLONING ARTIFACT SEQADV 1YC3 ARG A -5 UNP P07900 CLONING ARTIFACT SEQADV 1YC3 ASP A -4 UNP P07900 CLONING ARTIFACT SEQADV 1YC3 LEU A -3 UNP P07900 CLONING ARTIFACT SEQADV 1YC3 TYR A -2 UNP P07900 CLONING ARTIFACT SEQADV 1YC3 ASP A -1 UNP P07900 CLONING ARTIFACT SEQADV 1YC3 ASP A 0 UNP P07900 CLONING ARTIFACT SEQADV 1YC3 ASP A 1 UNP P07900 CLONING ARTIFACT SEQADV 1YC3 ASP A 2 UNP P07900 CLONING ARTIFACT SEQADV 1YC3 LYS A 3 UNP P07900 CLONING ARTIFACT SEQADV 1YC3 ASP A 4 UNP P07900 CLONING ARTIFACT SEQADV 1YC3 ARG A 5 UNP P07900 CLONING ARTIFACT SEQADV 1YC3 TRP A 6 UNP P07900 CLONING ARTIFACT SEQADV 1YC3 GLY A 7 UNP P07900 CLONING ARTIFACT SEQADV 1YC3 SER A 8 UNP P07900 CLONING ARTIFACT SEQRES 1 A 264 MET ARG GLY SER HIS HIS HIS HIS HIS HIS GLY MET ALA SEQRES 2 A 264 SER MET THR GLY GLY GLN GLN MET GLY ARG ASP LEU TYR SEQRES 3 A 264 ASP ASP ASP ASP LYS ASP ARG TRP GLY SER ASP GLN PRO SEQRES 4 A 264 MET GLU GLU GLU GLU VAL GLU THR PHE ALA PHE GLN ALA SEQRES 5 A 264 GLU ILE ALA GLN LEU MET SER LEU ILE ILE ASN THR PHE SEQRES 6 A 264 TYR SER ASN LYS GLU ILE PHE LEU ARG GLU LEU ILE SER SEQRES 7 A 264 ASN SER SER ASP ALA LEU ASP LYS ILE ARG TYR GLU THR SEQRES 8 A 264 LEU THR ASP PRO SER LYS LEU ASP SER GLY LYS GLU LEU SEQRES 9 A 264 HIS ILE ASN LEU ILE PRO ASN LYS GLN ASP ARG THR LEU SEQRES 10 A 264 THR ILE VAL ASP THR GLY ILE GLY MET THR LYS ALA ASP SEQRES 11 A 264 LEU ILE ASN ASN LEU GLY THR ILE ALA LYS SER GLY THR SEQRES 12 A 264 LYS ALA PHE MET GLU ALA LEU GLN ALA GLY ALA ASP ILE SEQRES 13 A 264 SER MET ILE GLY GLN PHE GLY VAL GLY PHE TYR SER ALA SEQRES 14 A 264 TYR LEU VAL ALA GLU LYS VAL THR VAL ILE THR LYS HIS SEQRES 15 A 264 ASN ASP ASP GLU GLN TYR ALA TRP GLU SER SER ALA GLY SEQRES 16 A 264 GLY SER PHE THR VAL ARG THR ASP THR GLY GLU PRO MET SEQRES 17 A 264 GLY ARG GLY THR LYS VAL ILE LEU HIS LEU LYS GLU ASP SEQRES 18 A 264 GLN THR GLU TYR LEU GLU GLU ARG ARG ILE LYS GLU ILE SEQRES 19 A 264 VAL LYS LYS HIS SER GLN PHE ILE GLY TYR PRO ILE THR SEQRES 20 A 264 LEU PHE VAL GLU LYS GLU ARG ASP LYS GLU VAL SER ASP SEQRES 21 A 264 ASP GLU ALA GLU HET 4BC A 237 27 HETNAM 4BC 4-(1,3-BENZODIOXOL-5-YL)-5-(5-ETHYL-2,4- HETNAM 2 4BC DIHYDROXYPHENYL)-2H-PYRAZOLE-3-CARBOXYLIC ACID FORMUL 2 4BC C19 H16 N2 O6 FORMUL 3 HOH *167(H2 O) HELIX 1 1 GLN A 23 THR A 36 1 14 HELIX 2 2 GLU A 42 THR A 65 1 24 HELIX 3 3 ASP A 66 ASP A 71 5 6 HELIX 4 4 THR A 99 LEU A 107 1 9 HELIX 5 5 GLY A 114 ALA A 124 1 11 HELIX 6 6 ASP A 127 GLY A 135 5 9 HELIX 7 7 VAL A 136 LEU A 143 5 8 HELIX 8 8 GLU A 192 LEU A 198 5 7 HELIX 9 9 GLU A 199 SER A 211 1 13 SHEET 1 A 8 GLU A 18 ALA A 21 0 SHEET 2 A 8 SER A 169 THR A 174 -1 O PHE A 170 N PHE A 20 SHEET 3 A 8 TYR A 160 SER A 164 -1 N ALA A 161 O ARG A 173 SHEET 4 A 8 ALA A 145 LYS A 153 -1 N VAL A 150 O TRP A 162 SHEET 5 A 8 GLY A 183 LEU A 190 -1 O ILE A 187 N THR A 149 SHEET 6 A 8 THR A 88 ASP A 93 -1 N ILE A 91 O VAL A 186 SHEET 7 A 8 ILE A 78 ASN A 83 -1 N ASN A 83 O THR A 88 SHEET 8 A 8 ILE A 218 LEU A 220 1 O THR A 219 N LEU A 80 SITE 1 AC1 14 ASN A 51 ALA A 55 LYS A 58 ASP A 93 SITE 2 AC1 14 ILE A 96 GLY A 97 MET A 98 PHE A 138 SITE 3 AC1 14 THR A 184 VAL A 186 HOH A 240 HOH A 247 SITE 4 AC1 14 HOH A 274 HOH A 284 CRYST1 52.775 44.829 53.157 90.00 114.62 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.018948 0.000000 0.008683 0.00000 SCALE2 0.000000 0.022307 0.000000 0.00000 SCALE3 0.000000 0.000000 0.020693 0.00000